A NEW GENERATION OF NANOMEDICINES
Arrogene is at the forefront of medical technology, creating a new generation of nano agents capable of delivering peptide, protein and oligonucleotide therapeutics across the blood-brain barrier to cancer cells to prevent tumor growth or for imaging.
Our technology leads the way in personalized cancer treatment. This unique nanomedicine platform can deliver multiple tumor inhibitors or imaging agents and is being tailored to fight different types of cancer.
NEW POSSIBILITIES FOR CANCER TREATMENT
♦ Targeted cancer-imaging drugs
♦ Immunochemistry for diagnostics and prognostics
♦ Readily-tailored, proprietary technology
♦ Non-immunogenic, non-toxic bio-polymer based